Lysosomal Sequestration of Sunitinib: A Novel Mechanism of Drug Resistance

Abstract

We report that sunitinib inhibits tumor cell proliferation at clinically relevant concentrations and found lysosomal sequestration to be a novel mechanism of sunitinib resistance. This finding warrants clinical evaluation whether targeting lysosomal function will overcome sunitinib resistance.